US Optical Biometry Devices Market Research Report: By Product [Swept-Source Optical Coherence Tomography (SSOCT) - Forecast to 2035

US Optical Biometry Devices Market Overview

As per MRFR analysis, the US Optical Biometry Devices Market Size was estimated at 37.82 (USD Million) in 2023. The US Optical Biometry Devices Market Industry is expected to grow from 42.5(USD Million) in 2024 to 99.5 (USD Million) by 2035. The US Optical Biometry Devices Market CAGR (growth rate) is expected to be around 8.04% during the forecast period (2025 - 2035).

Key US Optical Biometry Devices Market Trends Highlighted

The US Optical Biometry Devices Market is witnessing notable trends driven by advancements in technology and the increasing prevalence of vision-related disorders among the aging population. One of the key market drivers is the rise in cataract surgeries, as the US has one of the highest rates of such procedures, leading to a growing demand for precise measurement tools essential for intraocular lens (IOL) calculations. The technological innovations in optical biometry devices, such as non-contact measurements and improved imaging techniques, further enhance accuracy and patient comfort.

There are significant opportunities to be explored in the US market, particularly as healthcare providers seek to integrate these advanced devices into their practices to improve surgical outcomes. The shift toward value-based care is also creating a space for devices that offer better diagnostic capabilities and efficient patient management. Additionally, the ongoing development of mobile and portable biometry solutions stands to transform how these measurements are obtained and utilized in various clinical settings.

Trends in recent times show an increasing emphasis on personalized medicine, leading to a demand for biometrics that can cater to individual patient needs. The collaboration between technology developers and healthcare professionals in the US is becoming more prevalent, aiming to create devices that are user-friendly and enhance the patient experience.Moreover, regulatory pathways are being streamlined, offering an encouraging environment for new entrants aiming to innovate within the optical biometry sector. As awareness rises regarding eye health, especially among older adults, the landscape of the US Optical Biometry Devices Market is likely to continue evolving, fueled by these critical trends.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

US Optical Biometry Devices Market Drivers

Increasing Prevalence of Eye Disorders

The rise in various eye disorders, including cataracts and age-related macular degeneration, is a significant driver for the US Optical Biometry Devices Market Industry. According to the Centers for Disease Control and Prevention (CDC), an estimated 24 million Americans aged 40 and older have cataracts, and this number is projected to double by 2050. With an ever-increasing aging population, which the U.S. Census Bureau predicts will constitute over 20% of the population by 2030, there is a growing demand for advanced optical biometry devices that can assist in diagnosing and managing these conditions.

Leading organizations such as the American Academy of Ophthalmology have highlighted the necessity for improved diagnostic tools in eye care, catalyzing advancements in optical biometry technologies, thereby boosting market growth. The increasing adoption of these innovative devices for precise eye measurements underscores the need for continued development in the US Optical Biometry Devices Market.

Technological Advancements in Optical Biometry Devices

Technological innovation plays a critical role in the growth of the US Optical Biometry Devices Market Industry. Improvements in device accuracy, efficiency, and user-friendliness have led to an increased adoption of optical biometry devices among healthcare professionals. For instance, the introduction of swept-source optical coherence tomography has enhanced the precision of eye measurements, making it easier for ophthalmologists to perform surgeries.

According to a report from the Food and Drug Administration (FDA), the regulatory approval of several new optical biometry devices within the past few years indicates a robust pace of innovation in this sector. Established companies like Carl Zeiss AG and Alcon are at the forefront, continuously investing in Research and Development and emphasizing cutting-edge technologies, which is crucial for maintaining market momentum.

Rising Healthcare Expenditure

The increase in healthcare expenditure in the United States significantly impacts the US Optical Biometry Devices Market Industry positively. The National Health Expenditure Accounts (NHEA) report indicates that national health spending reached nearly 18% of the Gross Domestic Product (GDP) in 2021, reflecting a greater willingness among consumers to invest in health technologies that improve outcomes. This upward trend in healthcare spending is likely to continue, with projections estimating a rise to approximately 20% of GDP by 2028.

Such developments provide substantial opportunities for optical biometry device manufacturers as healthcare providers seek innovative solutions that enhance patient care while maximizing reimbursements. Major players, including Bausch + Lomb and Hoya Corporation, are scaling their product offerings to align with the increasing demand for advanced healthcare solutions in the optical sector.

US Optical Biometry Devices Market Segment Insights

Optical Biometry Devices Market Product [Swept-Source Optical Coherence Tomography Insights

The Swept-Source Optical Coherence Tomography (SSOCT) segment within the US Optical Biometry Devices Market is gaining recognition for its advanced imaging capabilities, which are critical for the accurate evaluation of ocular structures. This technology provides higher imaging speeds and deeper tissue penetration compared to traditional OCT systems, making it particularly useful in diagnosing and monitoring various eye conditions, including glaucoma and age-related macular degeneration. As the healthcare infrastructure in the US proves to be supportive of innovative diagnostic methodologies, SSOCT is becoming increasingly significant in ophthalmology.

The capacity of SSOCT to obtain high-resolution images of the anterior segment and retina allows for enhanced patient management and tailored treatment strategies. Furthermore, technological advancements continue to bolster the SSOCT market, with developments leading to smaller, more compact devices that enhance the convenience of use in clinical settings. This trend aligns with the growing need for non-invasive and precise diagnostic tools in America, where the aging population is leading to an increase in ocular diseases. As industry players focus on Research and Development, advancements in SSOCT technology promise to address existing limitations of earlier imaging systems, thereby expanding its application range.

In this dynamic market landscape, SSOCT not only demonstrates its importance by improving diagnostic accuracy but also contributes to better patient outcomes, which is becoming increasingly valuable in US healthcare systems focused on efficiency and effectiveness. The integration of telemedicine and increased demand for remote healthcare services further amplify the relevance of SSOCT, allowing healthcare professionals to share and analyze imaging data from diverse locations, thereby enhancing collaborative patient care. Overall, SSOCT stands as a pivotal segment within the US Optical Biometry Devices Market, demonstrating substantial growth potential and the capacity to revolutionize diagnostic practices in ophthalmology.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

US Optical Biometry Devices Market Key Players and Competitive Insights

The US Optical Biometry Devices Market is characterized by a dynamic landscape driven by advancements in technology and increasing demand for precise eye measurements in ophthalmic procedures. As the healthcare sector continues to evolve, the importance of innovative optical biometry devices becomes apparent, with manufacturers focusing on creating products that not only enhance accuracy but also improve patient outcomes. The competitive insights in this market reflect a blend of established players and emerging companies, all vying for market share through technological innovations, strategic collaborations, and expanded distribution channels. The US market is particularly noteworthy for its robust regulatory framework that guides product development, ensuring that devices meet stringent safety and efficacy standards. As healthcare providers seek sophisticated solutions for cataract surgeries and refractive procedures, companies are continuously adapting their strategies to maintain a competitive edge.

Acuity has established a strong presence in the US Optical Biometry Devices Market, capitalizing on its reputation for high-quality, reliable products. The company is recognized for its advanced optical biometry solutions that cater to ophthalmologists, enhancing preoperative planning and post-operative outcomes. Acuity's strength lies in its technologic advancements, which include features that improve measurement accuracy and speed, thereby reducing patient wait times and enhancing operational efficiency for eye care practices. The company has forged partnerships with leading healthcare institutions, increasing its visibility and credibility within the market. Acuity’s focus on customer support and training further solidifies its standing as a trusted provider, resonating well with eye care professionals seeking dependable biometry devices.

Visionix is another key player in the US Optical Biometry Devices Market, known for its innovative products that combine cutting-edge technology with user-friendly interfaces. The company's portfolio includes state-of-the-art devices that offer comprehensive biometric measurements, aiding in the diagnosis and treatment of various ocular conditions. Visionix emphasizes its commitment to research and development, continuously pushing the boundaries of optical technology to meet the changing needs of healthcare providers in the US. Its strengths lie in the reliability and scalability of its products, which have gained widespread adoption across leading ophthalmic institutions. Visionix has pursued strategic mergers and acquisitions to bolster its market presence and broaden its range of offerings, thereby ensuring sustained competitiveness within the rapidly evolving biometry landscape. Through a combination of innovative technology and a robust distribution network, Visionix remains poised to capture significant market share in the US optical biometry sector.

Key Companies in the US Optical Biometry Devices Market Include

• Acuity


• Visionix


• Nidek


• Bausch Health


• Medtronic


• Abbott Laboratories


• Carl Zeiss


• EssilorLuxottica


• Hoya Corporation


• Alcon


• Tomey


• Rayner


• Topcon


• Optovue


• Eyecare

US Optical Biometry Devices Market Industry Developments

The US Optical Biometry Devices Market has recently seen several significant developments impacting its trajectory. Companies such as Carl Zeiss, Alcon, and EssilorLuxottica have been actively enhancing their Optical Biometry offerings, focusing on integrating advanced technology to improve patient outcomes. Acuity has launched new devices that leverage artificial intelligence to enhance measurement accuracy.

In the merger and acquisition space, Bausch Health, in September 2023, completed the acquisition of an innovative Optical Biometry company to expand its product line and strengthen its market position. Medtronic has also introduced next-generation optical biometers that provide quicker and more accurate measurements, further reinforcing the competition in the sector. Notably, the increasing emphasis on personalized ophthalmic care is propelling the demand for these devices, with market valuations showing steady growth as healthcare providers seek to adopt cutting-edge technology for surgeries.

Furthermore, in 2021, Abbott Laboratories had made significant strides by enhancing their Optical Biometry portfolio, which has contributed to their positioning in the market. The regulatory environment in the US continues to evolve, fostering innovation while ensuring patient safety, highlighting the dynamic nature of the Optical Biometry Devices Market.

US Optical Biometry Devices Market Segmentation Insights

Optical Biometry Devices Market Product [Swept-Source Optical Coherence Tomography Outlook

• SSOCT

Report Scope:

Report Attribute/Metric Source:	Details
MARKET SIZE 2018	37.82(USD Million)
MARKET SIZE 2024	42.5(USD Million)
MARKET SIZE 2035	99.5(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	8.04% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	Acuity, Visionix, Nidek, Bausch Health, Medtronic, Abbott Laboratories, Carl Zeiss, EssilorLuxottica, Hoya Corporation, Alcon, Tomey, Rayner, Topcon, Optovue, Eyecare
SEGMENTS COVERED	Product [Swept-Source Optical Coherence Tomography
KEY MARKET OPPORTUNITIES	Increasing aging population, Advancements in optical technology, Rising prevalence of eye diseases, Growing demand for non-invasive procedures, Expanding applications in ophthalmology
KEY MARKET DYNAMICS	Technological advancements, Rising prevalence of eye disorders, Increasing geriatric population, Growing preference for minimally invasive procedures, Enhanced accuracy in measurements
COUNTRIES COVERED	US